Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ford Motor | William Clay Ford | Director, Executive Chair and Chair | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 1,464,460 | 1 (0%) | 0% | - | Common Stock, $0.01 par value | |
| Ford Motor | William Clay Ford | Director, Executive Chair and Chair | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 1,451,097 | 16,558,436 (0%) | 0% | - | Class B Stock, $0.01 par value | |
| Swarmer Inc | Philip Wagenheim | Director | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 1,124,981 | 0 | - | 0 | Common Stock | |
| Swarmer Inc | Philip Wagenheim | Director | 15 Sep 2026 | 899,988 | 0 | - | - | Warrants | ||
| Klaviyo Inc - Ordinary Shares - Series A | Erica Smith | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 821,917 | 821,917 | - | 0 | Series A Common Stock | |
| Swarmer Inc | Philip Wagenheim | Director | 15 Sep 2026 | 819,487 | 819,487 | - | 3.3 | 2,731,678 | Common Stock | |
| Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect | Sale of securities on an exchange or to another person at price $ 6.19 per share. | 15 Sep 2026 | 606,667 | 57,207,377 | - | 6.2 | 3,755,269 | Common Stock |
| 8X8 Inc | Colleen Martin-Garcia | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 600,000 | 600,000 (0%) | 0% | 0 | Common Stock | |
| Dolby Laboratories Inc (Class A) | Marc Whitten | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 600,000 | 600,000 | - | - | Performance-Based Restricted Stock Unit | |
| Marqeta Inc (Class A) | Eugenia Gibbons | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 497,863 | 497,863 | - | - | Restricted Stock Units | |
| Cerebras Systems Inc | Lior Susan | Director | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 451,115 | 6,941,829 | - | - | Class A Common Stock | |
| Klaviyo Inc - Ordinary Shares - Series A | Erica Smith | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 328,767 | 1,150,684 | - | 0 | Series A Common Stock | |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 315,000 | 315,000 | - | - | Employee Stock Option (Right to Buy) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 305,000 | 1,185,398 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 15 Sep 2026 | 305,000 | 61,555,422 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 15 Sep 2026 | 305,000 | 1,490,398 | - | 0 | Class A Common Stock | ||
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 4.72 per share. | 15 Sep 2026 | 300,000 | 1,170,056 | - | 4.7 | 1,416,000 | Class A Common Stock |
| FibroBiologics Inc | Hamid Khoja | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 298,508 | 298,508 | - | - | Warrant (Right to Buy) | |
| FibroBiologics Inc | Hamid Khoja | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 15 Sep 2026 | 298,508 | 301,571 | - | 1.7 | 500,001 | Common Stock |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CEO and Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 15 Sep 2026 | 282,001 | 1,004,363 | - | 3.9 | 1,099,804 | Class A Common Stock |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CEO and Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.90 per share. | 15 Sep 2026 | 282,001 | 722,362 | - | 10.9 | 3,073,811 | Class A Common Stock |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CEO and Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 282,001 | 2,131,195 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | James Edward Gute | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 260,315 | 260,315 | - | - | Restricted Stock Unit | |
| Nutanix Inc (Class A) | Rajiv Ramaswami | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.99 per share. | 15 Sep 2026 | 252,956 | 814,338 (0%) | 0% | 68.0 | 17,198,478 | Class A Common Stock |
| AN2 Therapeutics Inc | Cameron C Trenor | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 233,333 | 233,333 | - | - | Stock Option (right to by) | |
| Rocket Companies Inc (Class A) | Jay Bray | Director, Pres & CEO, Rocket Mortgage | Sale of securities on an exchange or to another person at price $ 13.11 per share. | 15 Sep 2026 | 225,000 | 7,953,027 | - | 13.1 | 2,949,750 | Class A common stock |
| Swarmer Inc | Justin Zeefe | Director | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 223,599 | 276,328 | - | 0 | Common Stock | |
| Neutron Holdings Inc | Wayne Ting | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 210,782 | 644,133 | - | 0 | Common Stock | |
| XBP Europe Holdings Inc | Par S. Chadha | Director | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 15 Sep 2026 | 204,946 | 204,946 | - | 2.8 | 579,997 | Common Stock, par value $0.0001 per share |
| DXC Tech Co | Paul J. Taylor | President, DXC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 204,280 | 204,280 (0%) | 0% | 0 | Common Stock | |
| Peloton Interactive Inc | Peter C. Stern | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 196,328 | 599,599 (1%) | 0% | - | Class A Common Stock | |
| Peloton Interactive Inc | Peter C. Stern | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 196,328 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 195,841 | 108,493 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.34 per share. | 15 Sep 2026 | 195,841 | 628,727 (1%) | 0% | 23.3 | 4,570,929 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 193,957 | 193,957 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 193,957 | 193,957 | - | - | Stock option (right to buy) | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 193,957 | 193,957 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 193,957 | 193,957 | - | - | Stock option (right to buy) | |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 15 Sep 2026 | 190,977 | 12,838,509 | - | - | Class B Common Stock | ||
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 15 Sep 2026 | 190,977 | 253,873 | - | 0 | Class A Common Stock | ||
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CEO and Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 15 Sep 2026 | 162,247 | 884,609 | - | 3.9 | 632,763 | Class A Common Stock |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CEO and Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 15 Sep 2026 | 162,247 | 722,362 | - | 10.5 | 1,710,083 | Class A Common Stock |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CEO and Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 162,247 | 1,968,948 | - | - | Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Marc Whitten | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 160,256 | 160,256 (0%) | 0% | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | 15 Sep 2026 | 154,893 | 0 | - | - | Class B Common Stock | ||
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 154,893 | 154,893 | - | - | Class B Common Stock | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 154,893 | 0 | - | - | Stock Option (Right to Buy) | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 15 Sep 2026 | 154,893 | 0 | - | 2.4 | 375,941 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | 15 Sep 2026 | 154,893 | 154,893 | - | 0 | Class A Common Stock | ||
| Fox Corp (Class A) | Lachlan K. Murdoch | Director, Executive Chair, CEO | Purchase of securities on an exchange or from another person at price $ 68.53 per share. | 15 Sep 2026 | 149,934 | 1,401,713 (0%) | 0% | 68.5 | 10,274,977 | Class A Common Stock |
| Fox Corp (Class A) | Lachlan K. Murdoch | Director, Executive Chair, CEO | Sale of securities on an exchange or to another person at price $ 68.53 per share. | 15 Sep 2026 | 149,934 | 152 (0%) | 0% | 68.5 | 10,274,977 | Class A Common Stock |
| Amcor | Peter Konieczny | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 147,295 | 147,295 | - | - | Employee Stock Options | |
| DXC Tech Co | Paul J. Taylor | President, DXC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 145,914 | 350,194 (0%) | 0% | 0 | Common Stock | |
| Interdigital Inc | Lawrence Chen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 137,400 | 652,289 | - | - | Employee Stock Option (Right-to-Buy) | |
| SoundHound AI Inc (Class A) | Keyvan Mohajer | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 15 Sep 2026 | 137,290 | 3,684,947 | - | 6.3 | 868,853 | Class A Common Stock |
| Planet Labs PBC (Class A) | William Marshall | Director, Co-Founder and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 15 Sep 2026 | 134,642 | 2,568,473 | - | 16.0 | 2,156,965 | Class A Common Stock |
| Guidewire Software Inc | Michael Rosenbaum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 123,074 | 353,156 (0%) | 0% | 0 | Common Stock | |
| Guidewire Software Inc | Michael Rosenbaum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 123,074 | 0 | - | - | Performance Shares | |
| Whitehawk Therapeutics Inc | Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 118,476 | 118,476 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 118,476 | 118,476 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 118,476 | 118,476 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 118,476 | 118,476 | - | - | Restricted Stock Units | |
| AN2 Therapeutics Inc | Cameron C Trenor | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 116,667 | 116,667 | - | 0 | Common Stock | |
| BILL Holdings Inc | Rene Lacerte | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 116,619 | 116,619 | - | - | Restricted Stock Units | |
| Peloton Interactive Inc | Nick Caldwell | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 115,741 | 1,176,253 (2%) | 0% | - | Class A Common Stock | |
| Peloton Interactive Inc | Nick Caldwell | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 115,741 | 462,963 | - | - | Restricted Stock Unit (RSU) | |
| Neutron Holdings Inc | Ann B. Gugino | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 110,661 | 265,328 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 110,000 | 1,604,765 | - | 0 | Common Stock | |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.34 per share. | 15 Sep 2026 | 108,493 | 541,379 (1%) | 0% | 23.3 | 2,532,227 | Common Stock |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 108,493 | 0 | - | - | Employee stock option (right to buy) | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 107,692 | 22,264,664 | - | - | Class B Common Stock | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 107,692 | 107,692 | - | - | Class A Common Stock | |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 101,734 | 253,133 | - | 0 | Class A Common Stock | |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 64.59 per share. | 15 Sep 2026 | 101,691 | 439,688 (1%) | 0% | 64.6 | 6,567,876 | Common Stock |
| Peloton Interactive Inc | Peter C. Stern | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.85 per share. | 15 Sep 2026 | 100,226 | 499,373 (1%) | 0% | 4.8 | 486,096 | Class A Common Stock |
| Redwood Trust Inc | Christopher J. Abate | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.84 per share. | 15 Sep 2026 | 100,000 | 679,283 (0%) | 0% | 3.8 | 383,900 | Common Stock |
| Innovate Corp | Paul K. Voigt | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 100,000 | 100,000 | - | - | Stock Opion (right to buy) | |
| INmune Bio Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 100,000 | 100,000 | - | - | Stock Options | |
| Climb Bio Inc | Stephen Thomas | Director | Sale of securities on an exchange or to another person at price $ 13.67 per share. | 15 Sep 2026 | 100,000 | 467,969 | - | 13.7 | 1,366,820 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.25 per share. | 15 Sep 2026 | 100,000 | 217,066 (0%) | 0% | 11.3 | 1,125,000 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 100,000 | 0 | - | - | Employee stock option (right to buy) | |
| Redwood Trust Inc | Christopher J. Abate | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.84 per share. | 15 Sep 2026 | 100,000 | 679,283 (0%) | 0% | 3.8 | 383,900 | Common Stock |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 63.26 per share. | 15 Sep 2026 | 99,716 | 529,011 (1%) | 0% | 63.3 | 6,307,964 | Common Stock |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 99,565 | 479,874 | - | 0 | Class A Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 99,565 | 0 | - | - | Performance Restricted Stock Units | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 15 Sep 2026 | 96,545 | 36,070,933 | - | - | Class B Common Stock | ||
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 15 Sep 2026 | 96,545 | 201,594 (0%) | 0% | 0 | Class A Common Stock | ||
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 63.64 per share. | 15 Sep 2026 | 96,125 | 432,886 (1%) | 0% | 63.6 | 6,117,289 | Common Stock |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 95,666 | 304,334 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.34 per share. | 15 Sep 2026 | 95,666 | 528,552 (1%) | 0% | 23.3 | 2,232,844 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.25 per share. | 15 Sep 2026 | 93,604 | 196,179 (0%) | 0% | 63.2 | 5,920,182 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 15 Sep 2026 | 93,289 | 2,017,439 | - | 10.7 | 1,001,028 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 91,633 | 91,633 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 91,633 | 91,633 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 91,633 | 91,633 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 91,633 | 91,633 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Eugenia Gibbons | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 87,858 | 87,858 | - | - | Performance Stock Units (Rule of 40) | |
| Bowman Consulting Grp Ltd | Gary Bowman | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 87,000 | 818,448 | - | 0 | Common Stock | |
| Whitehawk Therapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 85,887 | 85,887 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 85,887 | 85,887 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 85,887 | 85,887 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 85,887 | 85,887 | - | - | Restricted Stock Units | |
| Ford Motor | William Clay Ford | Director, Executive Chair and Chair | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 85,301 | 3,997,901 (0%) | 0% | - | Class B Stock, $0.01 par value | |
| Ford Motor | William Clay Ford | Director, Executive Chair and Chair | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 85,301 | 0 (0%) | 0% | - | Common Stock, $0.01 par value | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 15 Sep 2026 | 84,873 | 1,049,766 | - | 16.0 | 1,359,665 | Class A Common Stock |
| Whitehawk Therapeutics Inc | Margaret Dugan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 81,250 | 81,250 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Margaret Dugan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 81,250 | 81,250 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Margaret Dugan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 81,250 | 81,250 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Margaret Dugan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 81,250 | 81,250 | - | - | Restricted Stock Units | |
| Sphere Entertainment Co (Class A) | James L. Dolan | Director, Executive Chairman and CEO, Ten Percent Owner, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 80,689 | 0 | - | - | Performance Restricted Stock Units | |
| Sphere Entertainment Co (Class A) | James L. Dolan | Director, Executive Chairman and CEO, Ten Percent Owner, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 80,689 | 1,072,324 | - | 0 | Class A Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 79,181 | 2,051,197 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 79,181 | 475,088 | - | - | Restricted Stock Units | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.65 per share. | 15 Sep 2026 | 79,113 | 117,066 (0%) | 0% | 63.7 | 5,035,906 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.02 per share. | 15 Sep 2026 | 76,638 | 934,897 | - | 82.0 | 6,285,688 | Class A Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 76,463 | 152,925 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 76,463 | 1,972,016 | - | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.04 per share. | 15 Sep 2026 | 75,594 | 1,011,535 | - | 81.0 | 6,126,440 | Class A Common Stock |
| Nutanix Inc (Class A) | Rukmini Sivaraman | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.99 per share. | 15 Sep 2026 | 75,347 | 363,626 (0%) | 0% | 68.0 | 5,122,843 | Class A Common Stock |
| Guidewire Software Inc | John Mullen | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 75,211 | 223,330 (0%) | 0% | 0 | Common Stock | |
| Guidewire Software Inc | John Mullen | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 75,211 | 0 | - | - | Performance Shares | |
| Alliance Laundry Holdings Inc | Jan M.Gommaar Vleugels | COO - INTERNATIONAL | Sale of securities on an exchange or to another person at price $ 21.05 per share. | 15 Sep 2026 | 75,000 | 374,563 | - | 21.1 | 1,578,750 | Common Stock, par value $0.01 per share ("Common Stock") |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 15 Sep 2026 | 75,000 | 1,583,075 | - | 5.1 | 381,578 | Class A Common Stock |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 72,096 | 633,578 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 72,096 | 977,670 | - | 0 | Class A Common Stock | |
| KLA | Richard P. Wallace | President and CEO | Sale of securities on an exchange or to another person at price $ 171.88 per share. | 15 Sep 2026 | 72,019 | 706,924 (0%) | 0% | 171.9 | 12,378,626 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 15 Sep 2026 | 71,938 | 147,318 (0%) | 0% | 62.1 | 4,463,875 | Common Stock |
| SoundHound AI Inc (Class A) | Michael Zagorsek | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 15 Sep 2026 | 71,113 | 2,600,231 | - | 6.3 | 450,046 | Class A Common Stock |
| BILL Holdings Inc | Rohini Jain | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 67,681 | 67,681 | - | - | Restricted Stock Units | |
| Essential Properties Realty Trust Inc | Craig Vachris | Executive VP and CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 67,476 | 67,476 | - | - | OP Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 67,467 | 226,505 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 63.12 per share. | 15 Sep 2026 | 65,104 | 145,943 (0%) | 0% | 63.1 | 4,109,397 | Common Stock |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 61.99 per share. | 15 Sep 2026 | 63,907 | 130,488 (0%) | 0% | 62.0 | 3,961,851 | Common Stock |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 63,584 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 61.99 per share. | 15 Sep 2026 | 63,498 | 465,054 (1%) | 0% | 62.0 | 3,936,527 | Common Stock |
| Health In Tech Inc (Class A) | Tim Johnson | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 15 Sep 2026 | 63,339 | 23,271,026 | - | 0.9 | 56,372 | Class A Common Stock |
| Peloton Interactive Inc | Nick Caldwell | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.85 per share. | 15 Sep 2026 | 61,969 | 1,114,284 (2%) | 0% | 4.9 | 300,550 | Class A Common Stock |
| Oracle | Clayton M. Magouyrk | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 61,452 | 61,453 | - | - | Restricted Stock Unit | |
| Oracle | Clayton M. Magouyrk | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 61,452 | 195,570 (0%) | 0% | 0 | Common Stock | |
| Workiva Inc (Class A) | Martin J. Vanderploeg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 60,000 | 1,141,832 | - | - | Class B Common Stock | |
| Workiva Inc (Class A) | Martin J. Vanderploeg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 60,000 | 60,000 | - | - | Class B Common Stock | |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.62 per share. | 15 Sep 2026 | 60,000 | 5,537,105 | - | 5.6 | 337,362 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.68 per share. | 15 Sep 2026 | 60,000 | 5,417,105 | - | 5.7 | 340,524 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Sep 2026 | 60,000 | 5,477,105 | - | 5.6 | 333,264 | Class A Common Stock |
| Opendoor Tech Inc | Christina Schwartz | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 59,658 | 0 | - | - | Employee Stock Option | |
| Opendoor Tech Inc | Christina Schwartz | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.97 per share. | 15 Sep 2026 | 59,658 | 3,829,524 | - | 1.0 | 57,868 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 59,531 | 595,313 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 59,531 | 2,110,728 | - | 0 | Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. | 15 Sep 2026 | 58,493 | 380,309 | - | 80.9 | 4,731,499 | Class A Common Stock |
| Bowman Consulting Grp Ltd | Gary Bowman | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 58,000 | 1,295,338 | - | 0 | Common Stock | |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.88 per share. | 15 Sep 2026 | 57,500 | 211,047 (0%) | 0% | 26.9 | 1,545,600 | Common Stock |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 57,500 | 0 | - | - | Employee stock option (right to buy) | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Sale of securities on an exchange or to another person at price $ 16.96 per share. | 15 Sep 2026 | 55,663 | 577,915 | - | 17.0 | 944,312 | Class A Common Stock |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. | 15 Sep 2026 | 55,059 | 424,815 | - | 80.9 | 4,453,723 | Class A Common Stock |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.46 per share. | 15 Sep 2026 | 55,000 | 153,547 (0%) | 0% | 15.5 | 850,300 | Common Stock |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 55,000 | 0 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.46 per share. | 15 Sep 2026 | 55,000 | 272,066 (0%) | 0% | 15.5 | 850,300 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 55,000 | 0 | - | - | Employee stock option (right to buy) | |
| Planet Labs PBC (Class A) | Robert Schingler | Director, Co-Founder Chief Strategy Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 15 Sep 2026 | 54,117 | 771,424 | - | 16.0 | 866,954 | Class A Common Stock |
| Oracle | Michael D. Sicilia | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 52,673 | 185,434 (0%) | 0% | 0 | Common Stock | |
| Oracle | Michael D. Sicilia | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 52,673 | 52,674 | - | - | Restricted Stock Unit | |
| Planet Labs PBC (Class A) | Robert Schingler | Director, Co-Founder Chief Strategy Off. | Sale of securities on an exchange or to another person at price $ 16.96 per share. | 15 Sep 2026 | 52,240 | 170,171 | - | 17.0 | 886,225 | Class A Common Stock |
| Planet Labs PBC (Class A) | Robert Schingler | Director, Co-Founder Chief Strategy Off. | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 52,240 | 222,411 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Robert Schingler | Director, Co-Founder Chief Strategy Off. | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 52,240 | 719,184 | - | 0 | Class A Common Stock | |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.65 per share. | 15 Sep 2026 | 50,970 | 202,163 | - | 10.7 | 542,831 | Class A Common Stock |
| Redwood Trust Inc | Greg H. Kubicek | Director | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 15 Sep 2026 | 50,000 | 127,184 (0%) | 0% | 3.9 | 192,560 | Common Stock |
| SRM Entertainment Inc | Christopher Marc Melton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 15 Sep 2026 | 50,000 | 81,818 | - | 0.6 | 28,000 | Common Stock |
| SRM Entertainment Inc | Christopher Marc Melton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 50,000 | 0 | - | - | Stock option (right to buy) | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 50,000 | 4,816,425 | - | 0 | Class V Common Stock | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 15 Sep 2026 | 50,000 | 481,026 | - | 3.1 | 155,460 | Class A Common Stock |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 50,000 | 531,026 | - | 0 | Class A Common Stock | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 50,000 | 4,816,425 | - | - | ADK Class A Units | |
| LoanDepot Inc (Class A) | Dominick Edilio Marchetti | Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 48,790 | 97,580 | - | - | Restricted Stock Units | |
| LoanDepot Inc (Class A) | Dominick Edilio Marchetti | Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 48,790 | 48,933 (0%) | 0% | - | Class A Common Stock | |
| Teradata Corp | Michael D. Hutchinson | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 15 Sep 2026 | 48,077 | 171,927 (0%) | 0% | 30 | 1,442,310 | Common Stock |
| Dolby Laboratories Inc (Class A) | Mark Andrew Sherman | EVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 48,076 | 119,024 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 48,076 | 166,803 (0%) | 0% | 0 | Class A Common Stock | |
| Interdigital Inc | Lawrence Chen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 48,069 | 226,800 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 63.61 per share. | 15 Sep 2026 | 47,746 | 98,197 (0%) | 0% | 63.6 | 3,037,247 | Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 47,466 | 365,878 | - | 0 | Class A Common Stock | |
| Pinterest Inc (Class A) | Benjamin Silbermann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.64 per share. | 15 Sep 2026 | 46,875 | 0 (0%) | 0% | 18.6 | 873,600 | Class A Common Stock |
| Pinterest Inc (Class A) | Benjamin Silbermann | Director, Ten Percent Owner | 15 Sep 2026 | 46,875 | 34,424,388 | - | - | Class B Common Stock | ||
| Pinterest Inc (Class A) | Benjamin Silbermann | Director, Ten Percent Owner | 15 Sep 2026 | 46,875 | 46,875 (0%) | 0% | 0 | Class A Common Stock | ||
| Pinterest Inc (Class A) | Benjamin Silbermann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.22 per share. | 15 Sep 2026 | 46,875 | 0 (0%) | 0% | 19.2 | 900,923 | Class A Common Stock |
| Pinterest Inc (Class A) | Benjamin Silbermann | Director, Ten Percent Owner | 15 Sep 2026 | 46,875 | 34,471,263 | - | - | Class B Common Stock | ||
| Pinterest Inc (Class A) | Benjamin Silbermann | Director, Ten Percent Owner | 15 Sep 2026 | 46,875 | 46,875 (0%) | 0% | 0 | Class A Common Stock | ||
| BILL Holdings Inc | Michael Cieri | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 46,856 | 46,856 | - | - | Restricted Stock Units | |
| Sphere Entertainment Co (Class A) | David Granville-Smith | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 46,742 | 0 | - | - | Restricted Stock Units | |
| Sphere Entertainment Co (Class A) | David Granville-Smith | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 46,742 | 103,206 | - | 0 | Class A Common Stock | |
| Perdoceo Education Corporation | Todd S. Nelson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.89 per share. | 15 Sep 2026 | 46,199 | 301,782 (0%) | 0% | 32.9 | 1,519,485 | Common Stock |
| Amcor | Jean-Marc Galvez | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 45,632 | 45,632 | - | - | Employee Stock Options | |
| KLX Energy Services Holdings Inc | Max Bouthillette | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.49 per share. | 15 Sep 2026 | 44,677 | 225,697 (0%) | 0% | 1.5 | 66,569 | Common stock |
| Identiv Inc | Kristen F. Newquist | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Sep 2026 | 44,520 | 237,367 (1%) | 0% | 2.6 | 115,752 | Common Stock |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 44,234 | 125,663 (0%) | 0% | 0 | Common Stock | |
| Nutanix Inc (Class A) | Tarkan Maner | President and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.99 per share. | 15 Sep 2026 | 42,677 | 103,425 (0%) | 0% | 68.0 | 2,901,609 | Class A Common Stock |
| Amcor | Stephen R. Scherger | Executive VP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 42,387 | 42,387 | - | - | Employee Stock Options | |
| Opendoor Tech Inc | Christina Schwartz | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 15 Sep 2026 | 42,242 | 3,787,282 | - | 2.6 | 111,941 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.02 per share. | 15 Sep 2026 | 41,271 | 25,718 | - | 82.0 | 3,384,961 | Class A Common Stock |
| Sphere Entertainment Co (Class A) | James L. Dolan | Director, Executive Chairman and CEO, Ten Percent Owner, Member of 13(d) Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.12 per share. | 15 Sep 2026 | 41,191 | 1,031,133 | - | 144.1 | 5,936,447 | Class A Common Stock |
| Amcor | Ryan D. Yost | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 41,152 | 41,152 | - | - | Employee Stock Options | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.04 per share. | 15 Sep 2026 | 40,703 | 66,989 | - | 81.0 | 3,298,734 | Class A Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 83.03 per share. | 15 Sep 2026 | 40,609 | 894,288 | - | 83.0 | 3,371,680 | Class A Common Stock |
| Rackspace Tech Inc | Aaron Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 40,545 | 40,545 | - | 0 | Common Stock | |
| AMC Networks Inc (Class A) | Joseph M. Cohen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 40,206 | 3,647 | - | - | Restricted Stock Units | |
| AMC Networks Inc (Class A) | Joseph M. Cohen | Director | Sale or transfer of securities back to the company at price $ 12.27 per share. | 15 Sep 2026 | 40,206 | 0 (0%) | 0% | 12.3 | 493,328 | AMC Global Media Inc. Class A Common Stock |
| AMC Networks Inc (Class A) | Joseph M. Cohen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 15 Sep 2026 | 40,206 | 40,206 (0%) | 0% | 12.3 | 493,328 | AMC Global Media Inc. Class A Common Stock |
| GCM Grosvenor Inc (Class A) | Pamela L. Bentley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.56 per share. | 15 Sep 2026 | 40,000 | 24,397 | - | 12.6 | 502,508 | Class A Common Stock |
| Sprinklr Inc (Class A) | Amitabh Misra | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.73 per share. | 15 Sep 2026 | 40,000 | 814,779 | - | 5.7 | 229,200 | Class A Common Stock |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 39,650 | 350 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.96 per share. | 15 Sep 2026 | 39,650 | 194,395 (0%) | 0% | 18.0 | 712,114 | Common Stock |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 39,444 | 129,416 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 39,283 | 18,217 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.88 per share. | 15 Sep 2026 | 39,283 | 181,349 (0%) | 0% | 26.9 | 1,055,927 | Common Stock |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 39,000 | 0 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.25 per share. | 15 Sep 2026 | 39,000 | 154,745 (0%) | 0% | 25.3 | 984,750 | Common Stock |
| Samsara Inc (Class A) | Dominic Phillips | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.91 per share. | 15 Sep 2026 | 38,966 | 742,052 | - | 42.9 | 1,672,031 | Class A Common Stock |
| PaySign Inc | Joan M. Herman | Director, EVP, Operations | Sale of securities on an exchange or to another person at price $ 11.74 per share. | 15 Sep 2026 | 38,900 | 609,421 (1%) | 0% | 11.7 | 456,830 | Common Stock |
| SoundHound AI Inc (Class A) | James M. Hom | Director, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 15 Sep 2026 | 38,730 | 1,105,555 | - | 6.3 | 245,107 | Class A Common Stock |
| SoundHound AI Inc (Class A) | Majid Emami | CSO & SVP, Engineering, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 15 Sep 2026 | 38,730 | 834,253 | - | 6.3 | 245,107 | Class A Common Stock |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 38,150 | 457,800 | - | - | Restricted Stock Unit (RSU) | |
| Nutanix Inc (Class A) | Rukmini Sivaraman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 15 Sep 2026 | 38,139 | 325,487 (0%) | 0% | 70.0 | 2,669,806 | Class A Common Stock |
| Guidewire Software Inc | Jeffrey Elliott Cooper | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 37,826 | 0 | - | - | Performance Shares | |
| Guidewire Software Inc | Jeffrey Elliott Cooper | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 37,826 | 118,595 (0%) | 0% | 0 | Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 37,739 | 438,802 | - | 0 | Class A Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 37,739 | 75,479 | - | - | Restricted Stock Units | |
| ZipRecruiter Inc (Class A) | David Travers | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 15 Sep 2026 | 37,557 | 1,276,924 | - | 3.9 | 148,350 | Class A Common Stock |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 37,500 | 0 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.46 per share. | 15 Sep 2026 | 37,500 | 142,889 (0%) | 0% | 15.5 | 579,750 | Common Stock |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 36,904 | 401,063 | - | 0 | Class A Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 36,904 | 36,904 | - | - | Restricted Stock Units | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 36,526 | 28,474 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. | 15 Sep 2026 | 36,526 | 219,256 (0%) | 0% | 8.9 | 326,177 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 15 Sep 2026 | 36,000 | 262,064 | - | 1.0 | 36,360 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 36,000 | 150,120 | - | - | Stock Option (Right to Buy) | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 35,307 | 108,112 (0%) | 0% | 0 | Common Stock | |
| RxSight Inc | Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 15 Sep 2026 | 35,168 | 235,516 | - | 4.3 | 152,629 | Common Stock |
| RxSight Inc | Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 35,168 | 0 | - | - | Stock Option (right to buy) | |
| Weave Comm Inc | Brett T. White | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.33 per share. | 15 Sep 2026 | 34,793 | 2,885,156 | - | 7.3 | 255,033 | Common Stock |
| Health In Tech Inc (Class A) | Julia Qian | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 15 Sep 2026 | 33,725 | 8,964,667 | - | 0.9 | 30,015 | Class A Common Stock |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 15 Sep 2026 | 33,583 | 269,640 | - | 10.7 | 360,359 | Common Stock |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Sep 2026 | 33,454 | 193,051 (0%) | 0% | 0 | Common Stock | |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 15 Sep 2026 | 33,407 | 62,896 | - | 4.0 | 131,958 | Class A Common Stock |
| Sphere Entertainment Co (Class A) | David Granville-Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.12 per share. | 15 Sep 2026 | 32,582 | 82,803 | - | 144.1 | 4,695,718 | Class A Common Stock |
| Travere Therapeutics Inc | Jula Inrig | EVP, Head of R&D & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 32,395 | 43,605 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Jula Inrig | EVP, Head of R&D & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. | 15 Sep 2026 | 32,395 | 145,165 (0%) | 0% | 8.9 | 289,287 | Common Stock |
| XBP Europe Holdings Inc | Andrej Jonovic | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 15 Sep 2026 | 31,500 | 244,700 | - | 2.8 | 89,145 | Common Stock, par value $0.0001 per share |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 31,134 | 364,159 | - | 0 | Class A Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman & CEO, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 31,134 | 0 | - | - | Restricted Stock Units | |
| Apple | Jennifer G. Newstead | SVP, GC and Government Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 30,104 | 63,018 (0%) | 0% | - | Common Stock | |
| Apple | Jennifer G. Newstead | SVP, GC and Government Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 30,104 | 180,624 | - | - | Restricted Stock Unit | |
| Globus Medical Inc (Class A) | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 74.58 per share. | 15 Sep 2026 | 30,000 | 0 (0%) | 0% | 74.6 | 2,237,502 | Class A Common Stock |
| C3.ai Inc (Class A) | Hitesh Lath | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 29,856 | 29,856 | - | 0 | Class A Common Stock | |
| C3.ai Inc (Class A) | Hitesh Lath | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 29,856 | 341,180 | - | 0 | Class A Common Stock | |
| Sprinklr Inc (Class A) | Amitabh Misra | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Sep 2026 | 29,629 | 785,150 | - | 5.6 | 164,441 | Class A Common Stock |
| AMC Networks Inc (Class A) | Stephen C. Mills | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 15 Sep 2026 | 29,236 | 29,736 (0%) | 0% | 12.3 | 358,726 | AMC Global Media Inc. Class A Common Stock |
| AMC Networks Inc (Class A) | Stephen C. Mills | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 29,236 | 0 | - | - | Restricted Stock Units | |
| AMC Networks Inc (Class A) | Stephen C. Mills | Director | Sale or transfer of securities back to the company at price $ 12.27 per share. | 15 Sep 2026 | 29,236 | 500 (0%) | 0% | 12.3 | 358,726 | AMC Global Media Inc. Class A Common Stock |
| Microsoft | Bradford L. Smith | Vice Chair and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 29,077 | 473,793 (0%) | 0% | 0 | Common Stock | |
| Microsoft | Amy E. Hood | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 29,077 | 562,701 (0%) | 0% | 0 | Common Stock | |
| Microsoft | Judson B. Althoff | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 29,077 | 141,167 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | William E. Rote | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 62.66 per share. | 15 Sep 2026 | 29,021 | 101,467 (0%) | 0% | 62.7 | 1,818,317 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 10.19 per share. | 15 Sep 2026 | 28,914 | 1,988,525 | - | 10.2 | 294,663 | Common Stock |
| Travere Therapeutics Inc | Eric M. Dube | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 62.66 per share. | 15 Sep 2026 | 28,796 | 436,258 (1%) | 0% | 62.7 | 1,804,222 | Common Stock |
| Amcor | Ian Wilson | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 28,569 | 28,569 | - | - | Employee Stock Options | |
| Oracle | Mark Hura | Pres., Global Field Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 28,531 | 28,532 | - | - | Restricted Stock Unit | |
| Oracle | Mark Hura | Pres., Global Field Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 28,531 | 262,608 (0%) | 0% | 0 | Common Stock | |
| Lesaka Tech Inc | Ali Haeri Mazanderani | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.21 per share. | 15 Sep 2026 | 28,226 | 2,476,764 (4%) | 0% | 4.2 | 118,831 | Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 27,671 | 212,146 | - | - | Restricted Stock Unit (RSU) | |
| Travere Therapeutics Inc | Christopher Cline | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 15 Sep 2026 | 27,473 | 110,543 (0%) | 0% | 62.0 | 1,703,241 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 62.59 per share. | 15 Sep 2026 | 27,421 | 119,897 (0%) | 0% | 62.6 | 1,716,379 | Common Stock |
| D-Wave Quantum Inc | Mr. Gregory Golkov | Acting CFO & SVP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 27,081 | 426,872 | - | 0 | - | |
| DoubleVerify Holdings Inc | Steve John Mougis | Global Chief Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 27,056 | 54,112 | - | - | Restricted Stock Units | |
| DoubleVerify Holdings Inc | Steve John Mougis | Global Chief Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 27,056 | 128,768 | - | 0 | Common Stock | |
| Sphere Entertainment Co (Class A) | James L. Dolan | Director, Executive Chairman and CEO, Ten Percent Owner, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 26,897 | 1,005,365 | - | 0 | Class A Common Stock | |
| Sphere Entertainment Co (Class A) | James L. Dolan | Director, Executive Chairman and CEO, Ten Percent Owner, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 26,897 | 0 | - | - | Restricted Stock Units | |
| Sphere Entertainment Co (Class A) | David Granville-Smith | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 26,897 | 109,700 | - | 0 | Class A Common Stock | |
| Sphere Entertainment Co (Class A) | David Granville-Smith | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 26,897 | 0 | - | - | Performance Restricted Stock Units | |
| Gitlab Inc (Class A) | William Staples | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.25 per share. | 15 Sep 2026 | 26,425 | 732,403 | - | 49.2 | 1,301,431 | Class A Common Stock |
| Oracle | Stuart A Levey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 26,337 | 26,337 | - | - | Restricted Stock Unit | |
| Oracle | Stuart A Levey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 26,337 | 29,766 (0%) | 0% | 0 | Common Stock | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 15 Sep 2026 | 26,231 | 730,793 | - | 10.7 | 281,469 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.73 per share. | 15 Sep 2026 | 26,152 | 132,792 (0%) | 0% | 192.7 | 5,040,387 | Class A Common Stock |
| Redwood Trust Inc | Brooke E. Carillo | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 15 Sep 2026 | 26,065 | 140,481 (0%) | 0% | 3.8 | 100,238 | Common Stock |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 25,862 | 56,509 | - | 0 | Class A Common Stock | |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 25,862 | 129,310 | - | - | Restricted Stock Units | |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 25,556 | 230,004 | - | - | Restricted Stock Units | |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 25,556 | 82,065 | - | 0 | Class A Common Stock | |
| Oracle | Michael D. Sicilia | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.79 per share. | 15 Sep 2026 | 25,468 | 159,966 (0%) | 0% | 144.8 | 3,687,512 | Common Stock |
| Travere Therapeutics Inc | Jula Inrig | EVP, Head of R&D & CMO | Sale of securities on an exchange or to another person at price $ 62.02 per share. | 15 Sep 2026 | 25,390 | 119,775 (0%) | 0% | 62.0 | 1,574,604 | Common Stock |
| Amcor | Peter Konieczny | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 25,289 | 25,289 | - | - | Restricted Stock Units | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 190.71 per share. | 15 Sep 2026 | 25,163 | 176,431 (0%) | 0% | 190.7 | 4,798,760 | Class A Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.82 per share. | 15 Sep 2026 | 25,000 | 652,317 (1%) | 0% | 4.8 | 120,488 | Common Stock |
| Diamondback | Charles A. Meloy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 25,000 | 793,197 (0%) | 0% | 0 | Common Stock | |
| Diamondback | Charles A. Meloy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2026 | 25,000 | 28,257 (0%) | 0% | 0 | Common Stock | |
| IBEX Ltd | Robert Dechant | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.99 per share. | 15 Sep 2026 | 25,000 | 262,011 (1%) | 0% | 40.0 | 999,668 | Common Shares |
| LoanDepot Inc (Class A) | Dominick Edilio Marchetti | Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.73 per share. | 15 Sep 2026 | 24,825 | 24,108 (0%) | 0% | 0.7 | 18,167 | Class A Common Stock |
| Crown Castle | Christian H. Hillabrant | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 24,466 | 48,932 | - | - | Time RSUs | |
| Crown Castle | Christian H. Hillabrant | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 24,466 | 24,466 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Cerebras Systems Inc | Lior Susan | Director | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 24,463 | 315,124 | - | - | Class A Common Stock | |
| Compass Inc (Class A) | Scott Wahlers | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.65 per share. | 15 Sep 2026 | 24,297 | 341,581 | - | 10.6 | 258,763 | Class A Common Stock |
| Oracle | Clayton M. Magouyrk | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.79 per share. | 15 Sep 2026 | 24,182 | 171,388 (0%) | 0% | 144.8 | 3,501,312 | Common Stock |
| Acacia Research Corp | Isaac Theodore Kohlberg | Director | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 15 Sep 2026 | 24,000 | 54,310 (0%) | 0% | 4.6 | 109,200 | ACTG Common Stock |
| Swarmer Inc | Justin Zeefe | Director | Sale of securities on an exchange or to another person at price $ 24.12 per share. | 15 Sep 2026 | 23,885 | 252,443 | - | 24.1 | 576,195 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.57 per share. | 15 Sep 2026 | 23,875 | 108,917 (0%) | 0% | 193.6 | 4,621,572 | Class A Common Stock |
| Cerebras Systems Inc | Lior Susan | Director | Other type of transaction at price $ 0.00 per share. | 15 Sep 2026 | 23,734 | 278,775 | - | - | Class A Common Stock | |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 23,625 | 212,625 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 23,625 | 482,344 | - | 0 | Common Stock | |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 23,544 | 23,544 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 23,544 | 670,163 | - | 0 | Common Stock | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 23,141 | 69,424 | - | - | Restricted Stock Units | |
| DoubleVerify Holdings Inc | Mark S. Zagorski | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 22,919 | 603,283 | - | 0 | Common Stock | |
| DoubleVerify Holdings Inc | Mark S. Zagorski | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 22,919 | 206,243 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 22,812 | 114,063 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 22,812 | 458,719 | - | 0 | Common Stock | |
| P&G | Shailesh G. Jejurikar | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 22,787 | 22,787 | - | - | Stock Option (Right to Buy) | |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 15 Sep 2026 | 22,500 | 1,327,500 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 15 Sep 2026 | 22,500 | 1,189,857 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 15 Sep 2026 | 22,500 | 0 | - | 5.1 | 114,473 | Class A Common Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 15 Sep 2026 | 22,500 | 22,500 | - | 0 | Class A Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 15 Sep 2026 | 22,500 | 0 | - | 5.1 | 114,473 | Class A Common Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 15 Sep 2026 | 22,500 | 22,500 | - | 0 | Class A Common Stock | ||
| Mach Natural Resources LP - Units | William W. McMullen | Director, Ten Percent Owner, See Remarks | Purchase of securities on an exchange or from another person at price $ 11.25 per share. | 15 Sep 2026 | 22,124 | 22,124 | - | 11.3 | 248,895 | Common Units |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Sale of securities on an exchange or to another person at price $ 62.03 per share. | 15 Sep 2026 | 21,926 | 120,963 (0%) | 0% | 62.0 | 1,359,971 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 83.03 per share. | 15 Sep 2026 | 21,864 | 3,854 | - | 83.0 | 1,815,322 | Class A Common Stock |
| CME Group (Class A) | Terrence A. Duffy | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 275.09 per share. | 15 Sep 2026 | 21,812 | 62,442 (0%) | 0% | 275.1 | 6,000,263 | Common Stock Class A |
| Arbor Realty Trust Inc | Kevin Wachter | EVP, Asset Finance & Treasury | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 21,786 | 117,464 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| 908 Devices Inc | John Kenneweg | SVP, Sales & Product Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 21,399 | 5,257 | - | - | Stock Option (right to buy) | |
| 908 Devices Inc | John Kenneweg | SVP, Sales & Product Marketing | Sale of securities on an exchange or to another person at price $ 10.11 per share. | 15 Sep 2026 | 21,399 | 57,784 | - | 10.1 | 216,344 | Common Stock |
| 908 Devices Inc | John Kenneweg | SVP, Sales & Product Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share. | 15 Sep 2026 | 21,399 | 79,183 | - | 1.0 | 20,543 | Common Stock |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 21,113 | 211,125 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 21,113 | 287,660 | - | 0 | Common Stock | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 21,112 | 190,013 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 21,112 | 738,024 | - | 0 | Common Stock | |
| C3.ai Inc (Class A) | Hitesh Lath | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.48 per share. | 15 Sep 2026 | 21,077 | 371,036 | - | 10.5 | 220,887 | Class A Common Stock |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 21,052 | 0 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.33 per share. | 15 Sep 2026 | 21,052 | 27,403 (0%) | 0% | 3.3 | 70,103 | Common Stock |
| PaySign Inc | Joan M. Herman | Director, EVP, Operations | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 15 Sep 2026 | 21,004 | 648,321 (1%) | 0% | 12.4 | 260,069 | Common Stock |
| EverQuote Inc (Class A) | Jayme Mendal | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 24.27 per share. | 15 Sep 2026 | 20,981 | 591,160 (4%) | 0% | 24.3 | 509,209 | Class A Common Stock |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 15 Sep 2026 | 20,952 | 6,451 (0%) | 0% | 15.1 | 316,166 | Common Stock |
| Interdigital Inc | Lawrence Chen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 340.38 per share. | 15 Sep 2026 | 20,896 | 205,904 (0%) | 0% | 340.4 | 7,112,580 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 15 Sep 2026 | 20,846 | 746,345 | - | 25.0 | 521,775 | Common Stock |
| Travere Therapeutics Inc | Christopher Cline | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 62.61 per share. | 15 Sep 2026 | 20,735 | 89,808 (0%) | 0% | 62.6 | 1,298,175 | Common Stock |
| ZipRecruiter Inc (Class A) | David Travers | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,690 | 1,279,799 | - | 0 | Class A Common Stock | |
| ZipRecruiter Inc (Class A) | David Travers | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,690 | 103,450 | - | - | Restricted Stock Units | |
| Sphere Entertainment Co (Class A) | Jennifer Koester | President & COO, Sphere | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,487 | 64,665 | - | 0 | Class A Common Stock | |
| Sphere Entertainment Co (Class A) | Jennifer Koester | President & COO, Sphere | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,487 | 0 | - | - | Performance Restricted Stock Units | |
| Amcor | Deborah M. Rasin | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2026 | 20,480 | 20,480 | - | - | Employee Stock Options | |
| ZipRecruiter Inc (Class A) | Boris F. Shimanovsky | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,444 | 443,765 | - | 0 | Class A Common Stock | |
| ZipRecruiter Inc (Class A) | Boris F. Shimanovsky | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,444 | 183,992 | - | - | Restricted Stock Units | |
| ZipRecruiter Inc (Class A) | David Travers | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,444 | 183,992 | - | - | Restricted Stock Units | |
| ZipRecruiter Inc (Class A) | David Travers | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,444 | 1,300,243 | - | 0 | Class A Common Stock | |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,388 | 40,775 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,388 | 122,325 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,388 | 246,159 | - | 0 | Common Stock | |
| Wealthfront Corp | Kal Iyer | VP, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,388 | 266,547 | - | 0 | Common Stock | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,387 | 101,938 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,387 | 716,912 | - | 0 | Common Stock | |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 15 Sep 2026 | 20,304 | 479,802 | - | 10.7 | 217,870 | Common Stock |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,007 | 40,013 | - | - | Restricted Stock Units | |
| C3.ai Inc (Class A) | Hitesh Lath | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,000 | 240,000 | - | - | Restricted Stock Units | |
| C3.ai Inc (Class A) | Hitesh Lath | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,000 | 392,113 | - | - | Class A Common Stock | |
| Travere Therapeutics Inc | Christopher Cline | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 20,000 | 0 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Christopher Cline | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.44 per share. | 15 Sep 2026 | 20,000 | 138,016 (0%) | 0% | 17.4 | 348,800 | Common Stock |
| Meta | Christopher K. Cox | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 675.23 per share. | 15 Sep 2026 | 20,000 | 224,516 (0%) | 0% | 675.2 | 13,504,556 | Class A Common Stock |
| Solidion Tech Inc | John Linzy Davis | Director | Sale or transfer of securities back to the company at price $ 7.03 per share. | 15 Sep 2026 | 19,915 | 32,938 | - | 7.0 | 140,002 | Common Stock |
| Madison Square Garden Entertainment Corp (Class A) | Philip Gerard D’Ambrosio | EVP and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,913 | 44,740 | - | 0 | Class A Common Stock | |
| Madison Square Garden Entertainment Corp (Class A) | Philip Gerard D’Ambrosio | EVP and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,913 | 0 | - | - | Performance Restricted Stock Units | |
| Compass Inc (Class A) | Scott Wahlers | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,795 | 230,946 | - | - | Restricted Stock Unit (RSU) | |
| Oracle | Jeffrey O. Henley | Director, Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,752 | 475,662 (0%) | 0% | 0 | Common Stock | |
| Oracle | Jeffrey O. Henley | Director, Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,752 | 19,753 | - | - | Restricted Stock Unit | |
| Guidewire Software Inc | James Winston King | Chief Admin Officer, Gen Couns | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,701 | 0 | - | - | Performance Shares | |
| Guidewire Software Inc | James Winston King | Chief Admin Officer, Gen Couns | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,701 | 57,753 (0%) | 0% | 0 | Common Stock | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Sep 2026 | 19,559 | 109,857 (0%) | 0% | 0 | Common Stock | |
| Weave Comm Inc | Joseph David McNeil | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.33 per share. | 15 Sep 2026 | 19,140 | 733,200 | - | 7.3 | 140,296 | Common Stock |
| 8X8 Inc | Samuel Wilson | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.83 per share. | 15 Sep 2026 | 19,080 | 2,552,626 (2%) | 0% | 1.8 | 34,916 | Common Stock |
| ZipRecruiter Inc (Class A) | Boris F. Shimanovsky | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 15 Sep 2026 | 19,028 | 438,975 | - | 4.0 | 75,161 | Class A Common Stock |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,000 | 247,000 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Julien Wetterwald | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 19,000 | 757,024 | - | 0 | Common Stock | |
| Beneficient (Class A) | Peter T. Cangany | Director | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 15 Sep 2026 | 18,868 | 98,529 | - | 1.1 | 20,000 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 18,500 | 488,801 | - | - | Stock Option (Right to Buy) | |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 37.00 per share. | 15 Sep 2026 | 18,500 | 235,244 | - | 37 | 684,500 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 15 Sep 2026 | 18,500 | 253,744 | - | 2.9 | 53,591 | Class A Common Stock |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 18,421 | 0 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.04 per share. | 15 Sep 2026 | 18,421 | 24,772 (0%) | 0% | 3.0 | 56,000 | Common Stock |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 15 Sep 2026 | 18,321 | 6,451 (0%) | 0% | 15.1 | 276,464 | Common Stock |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 18,277 | 71,092 (0%) | 0% | 0 | Common Stock | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 18,277 | 71,092 (0%) | 0% | 0 | Common Stock | |
| HawkEye 360 Inc | Michael Scott Turner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 16.24 per share. | 15 Sep 2026 | 18,256 | 179,521 | - | 16.2 | 296,419 | Common Stock |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 18,082 | 90,415 | - | - | 2026 Cash Settled Restricted Stock Units | |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 18,082 | 2,717,694 (0%) | 0% | - | Common Stock | |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Sale or transfer of securities back to the company at price $ 59.52 per share. | 15 Sep 2026 | 18,082 | 2,699,612 (0%) | 0% | 59.5 | 1,076,241 | Common Stock |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 17,762 | 500,106 | - | 0 | Common Stock | |
| Wealthfront Corp | Alan Imberman | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 17,762 | 230,913 | - | - | Restricted Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Sep 2026 | 17,730 | 107,933 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.88 per share. | 15 Sep 2026 | 17,717 | 289,783 (0%) | 0% | 26.9 | 476,233 | Common Stock |
| Travere Therapeutics Inc | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 17,717 | 500 | - | - | Employee stock option (right to buy) | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Sep 2026 | 17,508 | 90,604 (0%) | 0% | 0 | Common Stock | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.63 per share. | 15 Sep 2026 | 17,487 | 158,944 (0%) | 0% | 191.6 | 3,350,994 | Class A Common Stock |
| IBEX Ltd | Julie Casteel | Chief Sales/Marketing Officer | Sale of securities on an exchange or to another person at price $ 40.41 per share. | 15 Sep 2026 | 17,474 | 100,814 (0%) | 0% | 40.4 | 706,065 | Common Shares |
| Ichor Holdings Ltd | Iain Mackenzie | Director | Sale of securities on an exchange or to another person at price $ 50.52 per share. | 15 Sep 2026 | 17,400 | 105,027 (0%) | 0% | 50.5 | 879,048 | Ordinary Shares, par value $0.0001 |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.